Exchange: NASDAQ·Updated 07:30 PM EDT
RLMD logo

RLMD Relmada Therapeutics Inc

$4.33
$0.19
(4.20%)
Today
Closed $4.33
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$461.88M
Vol678,359.00

About RLMD

Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
42

Bearish Sentiment

How do you feel about RLMD?

Advertisement|Remove ads.